EPILIM Powder and solvent for solution for injection / infusion Ref.[7407] Active ingredients: Valproic acid

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom Or trading as: Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom

Product name and form

Epilim 400 mg Powder and Solvent for solution for injection/infusion.

Pharmaceutical Form

Powder and Solvent for solution for injection/infusion.

The powder is hygroscopic, white or practically white crystalline.

The solvent is a clear, colourless solution.

Qualitative and quantitative composition

Each vial of freeze-dried powder contains 400 mg of the active substance Sodium Valproate.

Each ampoule of solvent contains 4 ml of Water for Injection.

For full list of excipients, see section 6.1.

Active Ingredient Description
Valproic acid

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.

List of Excipients

Powder: None

Solvent: None

Pack sizes and marketing

Colourless, Type I glass vial flat base for lyophilisation. Closed by a slotted, chlorobutyl rubber stopper, secured by an aluminium collar and a plastic flip-off cap. The vial is supplied packed in a cardboard carton along with one colourless Type I glass, bottle-shaped ampoule containing 4 ml of solvent (Water for Injection).

Marketing authorization holder

Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom

Or trading as: Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom

Marketing authorization dates and numbers

PL 04425/0685

Date of First Authorisation: 18 August 1993
Date of Latest Renewal: 28 May 2004

Drugs

Drug Countries
EPILIM Australia, Hong Kong, Ireland, Malta, Nigeria, New Zealand, Singapore, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.